Indinavir/ritonavir-based therapy in HIV-1-infected antiretroviral therapy-naive patients: comparison of 800/100 mg and 400/100 mg twice daily.
about
Lack of indinavir-associated nephrological complications in HIV-infected adults (predominantly women) with high indinavir plasma concentration in Abidjan, Côte d'Ivoire.Indinavir: the forgotten HIV-protease inhibitor. Does it still have a role?Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges.Comparison of the Effectiveness of Low-Dose Indinavir/Ritonavir (IDV/r)- versus Atazanavir/Ritonavir (ATV/r)-Based Generic Antiretroviral Therapy in NNRTI-Experienced HIV-1-Infected Patients in India.Evaluation of universal versus genotype-guided efavirenz dose reduction in pregnant women using population pharmacokinetic modelling.
P2860
Indinavir/ritonavir-based therapy in HIV-1-infected antiretroviral therapy-naive patients: comparison of 800/100 mg and 400/100 mg twice daily.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Indinavir/ritonavir-based ther ...... mg and 400/100 mg twice daily.
@en
Indinavir/ritonavir-based ther ...... mg and 400/100 mg twice daily.
@nl
type
label
Indinavir/ritonavir-based ther ...... mg and 400/100 mg twice daily.
@en
Indinavir/ritonavir-based ther ...... mg and 400/100 mg twice daily.
@nl
prefLabel
Indinavir/ritonavir-based ther ...... mg and 400/100 mg twice daily.
@en
Indinavir/ritonavir-based ther ...... mg and 400/100 mg twice daily.
@nl
P2093
P2860
P1433
P1476
Indinavir/ritonavir-based ther ...... mg and 400/100 mg twice daily.
@en
P2093
P2860
P356
10.1111/J.1468-1293.2005.00255.X
P577
2005-01-01T00:00:00Z